Dermatology Times » Rosacea
244 FOLLOWERS
Dermatology Times is a publication focused on the field of dermatology, founded in 1971. Their content covers a range of topics related to dermatology, including news, research, clinical insights, and industry updates. Get the latest news and trends in dermatologic procedures, therapy, technology, products and drugs at Dermatology Times.
Dermatology Times » Rosacea
3h ago
Scurto presented integrative medicine pearls at the 2024 Diversity in Dermatology meeting ..read more
Dermatology Times » Rosacea
6h ago
Noor, the co-owner of Rao Dermatology, shares about his interests in dermatology and what he most looks forward to as a member of our board ..read more
Dermatology Times » Rosacea
9h ago
Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted ..read more
Dermatology Times » Rosacea
11h ago
Data stems from week 28 results of the German G-EPOSS study evaluating the effectiveness of guselkumab in skin health, quality of life, sexuality, and stigmatization ..read more
Dermatology Times » Rosacea
1d ago
Nivolumab plus talazoparib did not produce RECIST-based tumor responses in heavily pretreated patients with unresectable or metastatic melanoma ..read more
Dermatology Times » Rosacea
1d ago
Researchers recently developed and validated the 3-question social comparison scale, which may be applicable outside of conditions such as eczema and psoriasis ..read more
Dermatology Times » Rosacea
1d ago
Addressing gender inequity in academic dermatology involves strengthening societies, celebrating female dermatologists, promoting leadership, and equitable representation, authors wrote ..read more
Dermatology Times » Rosacea
2d ago
The WHO underscores the significance of addressing scabies as a neglected skin disease, especially in regions with limited health care access ..read more
Dermatology Times » Rosacea
2d ago
A study demonstrated the favorable efficacy and safety profiles of secukinumab in patients with severe HS for up to 52 weeks ..read more
Dermatology Times » Rosacea
2d ago
Interim findings from the PROSPER study of mogamulizumab in adults with CTCL were recently presented orally ..read more